Candida Blankii Candidemia an Emerging Threat
Abstract
No Abstract
1. Delaloye J, Calandra T (2014). Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence, 5(1):161-9.
2. Lamoth F, Lockhart SR, Berkow EL, Calandra T(2018). Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother,73(suppl_1):i4-i13.
3. Buckley HR, van Uden N (1968). Five new Candida species. Mycopathol Mycol Appl, 36(3):257-66.
4. Nobrega de Almeida J, Campos SV, Thomaz DY, et al (2018). Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals. Emerg Microbes Infect , 7(1):24.
5. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsåker T, Gaustad P (2006). Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol, 44(6):1977-81.
6. Arzumanyan VG, Magarshak OO, Semenov BF (2000). Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. Bull Exp Biol Med, 129(6):601-4.
7. Zaragoza S, Galanternik L, Vazquez M, Teper A, Córdoba S, Finquelievich J (2015). 318 Candida blankii: New agent in cystic fibrosis airways? Journal of Cystic Fibrosis, 14:S140.
8. Al-Haqqan A, Al-Sweih N, Ahmad S, et al (2018). Azole-resistant Candida blankii as a newly recognized cause of bloodstream infection. New Microbes New Infect, 26:25-9.
9. Chowdhary A, Stielow JB, Upadhyaya G, Singh PK, Singh A, Meis JF (2020). Candida blankii: an emerging yeast in an outbreak of fungaemia in neonates in Delhi, India. Clin Microbiol Infect, 26(5):648.e5-.e8.
2. Lamoth F, Lockhart SR, Berkow EL, Calandra T(2018). Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother,73(suppl_1):i4-i13.
3. Buckley HR, van Uden N (1968). Five new Candida species. Mycopathol Mycol Appl, 36(3):257-66.
4. Nobrega de Almeida J, Campos SV, Thomaz DY, et al (2018). Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals. Emerg Microbes Infect , 7(1):24.
5. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsåker T, Gaustad P (2006). Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol, 44(6):1977-81.
6. Arzumanyan VG, Magarshak OO, Semenov BF (2000). Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. Bull Exp Biol Med, 129(6):601-4.
7. Zaragoza S, Galanternik L, Vazquez M, Teper A, Córdoba S, Finquelievich J (2015). 318 Candida blankii: New agent in cystic fibrosis airways? Journal of Cystic Fibrosis, 14:S140.
8. Al-Haqqan A, Al-Sweih N, Ahmad S, et al (2018). Azole-resistant Candida blankii as a newly recognized cause of bloodstream infection. New Microbes New Infect, 26:25-9.
9. Chowdhary A, Stielow JB, Upadhyaya G, Singh PK, Singh A, Meis JF (2020). Candida blankii: an emerging yeast in an outbreak of fungaemia in neonates in Delhi, India. Clin Microbiol Infect, 26(5):648.e5-.e8.
| Files | ||
| Issue | Vol 52 No 1 (2023) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v52i1.11686 | |
| Keywords | ||
| Candidemia Candida blankii Antifungal resistance | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Ahmadkhani F, Golrizi M, Khodavaisy S, Daie Ghazvini R. Candida Blankii Candidemia an Emerging Threat. Iran J Public Health. 2023;52(1):208-209.
